Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 43, 2024 - Issue 3
128
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Primary orbital sarcoma in adults: a case series with emphasis on post-irradiation sarcoma

ORCID Icon &
Pages 417-428 | Received 26 Aug 2022, Accepted 15 Dec 2022, Published online: 09 Jan 2023

References

  • Bonavolontà G, Strianese D, Grassi P, Comune C, Tranfa F, Uccello G, et al. An analysis of 2,480 space-occupying lesions of the orbit from 1976 to 2011. Ophthalmic Plast Reconstr Surg. 2013;29(2):79–86. doi:10.1097/IOP.0b013e31827a7622.
  • Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 montgomery lecture, part 1. Ophthalmology. 2004;111(5):997–1008. doi:10.1016/j.ophtha.2003.01.002.
  • Murray EM, Werner D, Greeff EA, Taylor DA. Postradiation sarcomas: 20 cases and a literature review. Int J Radiat Oncol Biol Phys. 1999;45(4):951–961. doi:10.1016/s0360-3016(99)00279-5.
  • Smith SC, Gooding WE, Elkins M, Patel RM, Harms PW, McDaniel AS, et al. Solitary fibrous tumors of the head and neck: a multi-institutional clinicopathologic study. Am J Surg Pathol. 2017;41(12):1642–1656. doi:10.1097/PAS.0000000000000940.
  • Yamamoto Y, Hayashi Y, Sakaki H, Murakami I. Fascin‑1 is associated with recurrence in solitary fibrous tumor/hemangiopericytoma. Mol Clin Oncol. 2021;15(4):1–6. doi:10.3892/mco.2021.2361.
  • Kazazian K, Demicco EG, de Perrot M, Strauss D, Swallow CJ. Toward better understanding and management of solitary fibrous tumor. Surg Oncol Clin N Am. 2022;31(3):459–483. doi:10.1016/j.soc.2022.03.009.
  • Yang BT, Wang YZ, Dong JY, Wang XY, Wang ZC. MRI study of solitary fibrous tumor in the orbit. AJR Am J Roentgenol. 2012;199(4):W506–511. doi:10.2214/AJR.11.8477.
  • Blessing NW, Bermudez-Magner JA, Fernandez MP, Rosenberg AE, Dubovy SR, Johnson TE. Solitary fibrous tumor of the orbit: a case series with clinicopathologic correlation and evaluation of STAT6 as a diagnostic marker. Ophthalmic Plast Reconstr Surg. 2020;36(2):164–171. doi:10.1097/IOP.0000000000001504.
  • The WHO Classification of Tumours Editorial Board. WHO Classification of Tumours. Soft Tissue and Bone Tumours. 5th ed. Lyon: IARC Press ; 2020.
  • van Houdt WJ, Westerveld CMA, Vrijenhoek JEP, van Gorp J, van Coevorden F, Verhoef C, et al. Prognosis of solitary fibrous tumors: a multicenter study. Ann Surg Oncol. 2013;20(13):4090–4095. doi:10.1245/s10434-013-3242-9.
  • Demicco EG, Wagner MJ, Maki RG, Gupta V, Iofin I, Lazar AJ, et al. Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model. Mod Pathol. 2017;30(10):1433–1442. doi:10.1038/modpathol.2017.54.
  • Gold JS, Antonescu CR, Hajdu C, Ferrone CR, Hussain M, Lewis JJ, et al. Clinicopathologic correlates of solitary fibrous tumors. Cancer. 2002;94(4):1057–1068. doi:10.1002/cncr.10328.
  • Cranshaw IM, Gikas PD, Fisher C, Thway K, Thomas JM, Hayes AJ. Clinical outcomes of extra-thoracic solitary fibrous tumours. Eur J Surg Oncol. 2009;35(9):994–998. doi:10.1016/j.ejso.2009.02.015.
  • Rice CD, Kersten RC, Mrak RE. An orbital hemangiopericytoma recurrent after 33 years. Arch Ophthalmol. 1989;107(4):552–556. doi:10.1001/archopht.1989.01070010566033.
  • Dorfman DM, To K, Dickersin GR, Rosenberg AE, Pilch BZ. Solitary fibrous tumor of the orbit. Am J Surg Pathol. 1994;18(3):281–287. doi:10.1097/00000478-199403000-00008.
  • Karcioglu ZA, Nasr AM, Haik BG. Orbital hemangiopericytoma: clinical and morphologic features. Am J Ophthalmol. 1997;124(5):661–672. doi:10.1016/s0002-9394(14)70904-3.
  • Ing EB, Kennerdell JS, Olson PR, Ogino S, Rothfus WE. Solitary fibrous tumor of the orbit. Ophthalmic Plast Reconstr Surg. 1998;14(1):57–61. doi:10.1097/00002341-199801000-00012.
  • de Saint Aubain Somerhausen N, Rubin BP, Fletcher CD. Myxoid solitary fibrous tumor: a study of seven cases with emphasis on differential diagnosis. Mod Pathol. 1999;12:463–471.
  • Woo KI, Suh YL, Kim YD. Solitary fibrous tumor of the lacrimal sac. Ophthalmic Plast Reconstr Surg. 1999;15(6):450–453. doi:10.1097/00002341-199911000-00018.
  • Alexandrakis G, Johnson TE. Recurrent orbital solitary fibrous tumor in a 14-year-old girl. Am J Ophthalmol. 2000;130(3):373–376. doi:10.1016/s0002-9394(00)00545-6.
  • Hayashi S, Kurihara H, Hirato J, Sasaki T. Solitary fibrous tumor of the orbit with extraorbital extension: case report. Neurosurgery. 2001;49(5):1241–1245. doi:10.1227/00006123-200111000-00042.
  • Polito E, Tosi GM, Toti P, Schürfeld K, Caporossi A. Orbital solitary fibrous tumor with aggressive behavior. Three cases and review of the literature. Graefes Arch Clin Exp Ophthalmol. 2002;240(7):570–574. doi:10.1007/s00417-002-0486-7.
  • Krishnakumar S, Subramanian N, Mohan ER, Mahesh L, Biswas J, Rao NA. Solitary fibrous tumor of the orbit: a clinicopathologic study of six cases with review of the literature. Surv Ophthalmol. 2003;48(5):544–554. doi:10.1016/s0039-6257(03)00087-0.
  • Bernardini FP, de Conciliis C, Schneider S, Kersten RC, Kulwin DR. Solitary fibrous tumor of the orbit: is it rare? Report of a case series and review of the literature. Ophthalmology. 2003;110(7):1442–1448. doi:10.1016/S0161-6420(03)00459-7.
  • Romer M, Bode B, Schuknecht B, Schmid S, Holzmann D. Solitary fibrous tumor of the orbit–two cases and a review of the literature. Eur Arch Otorhinolaryngol. 2005;262(2):81–88. doi:10.1007/s00405-003-0731-7.
  • Ness GO, Lybaek H, Arnes J, Rødahl E. Chromosomal imbalances in a recurrent solitary fibrous tumor of the orbit. Cancer Genet Cytogenet. 2005;162(1):38–44. doi:10.1016/j.cancergencyto.2005.01.014.
  • Tam ES, Chen EC, Nijhawan N, Harvey JT, Howarth D, Oestreicher JH. Solitary fibrous tumor of the orbit: a case series. Orbit. 2008;27(6):426–431. doi:10.1080/01676830802344508.
  • Carrera M, Prat J, Quintana M. Malignant solitary fibrous tumour of the orbit: report of a case with 8 years follow-up. Eye (Lond). 2001;15(Pt 1):102–104. doi:10.1038/eye.2001.24.
  • Manousaridis K, Stropahl G, Guthoff RF. Recurrent malignant solitary fibrous tumor of the orbit. Ophthalmologe. 2011;108(3):260–264. doi:10.1007/s00347-010-2277-6.
  • Young TK, Hardy TG. Solitary fibrous tumor of the orbit with intracranial involvement. Ophthalmic Plast Reconstr Surg. 2011;27(3):e74–76. doi:10.1097/IOP.0b013e3181ed3590.
  • Wang X, Qian J, Bi Y, Ping B, Zhang R. Malignant transformation of orbital solitary fibrous tumor. Int Ophthalmol. 2013;33(3):299–303. doi:10.1007/s10792-012-9637-y.
  • Blandamura S, Alaggio R, Bettini G, Guzzardo V, Valentini E, Bedogni A. Four cases of solitary fibrous tumour of the eye and orbit: one with sarcomatous transformation after radiotherapy and one in a 5-year-old child’s eyelid. J Clin Pathol. 2014;67(3):263–267. doi:10.1136/jclinpath-2013-201820.
  • Griepentrog GJ, Harris GJ, Zambrano EV. Multiply recurrent solitary fibrous tumor of the orbit without malignant degeneration: a 45-year clinicopathologic case study. JAMA Ophthalmol. 2013;131(2):265–267. doi:10.1001/2013.jamaophthalmol.69.
  • Parrozzani R, Fusetti S, Montesco C, Favero V, Midena E. Biphasic solitary fibrous tumor of the orbit with distant metastases. Int Ophthalmol. 2013;33(6):701–705. doi:10.1007/s10792-012-9706-2.
  • Chakrabartty H, Singhvi S, Purohit D, Mittal RS. Malignant solitary fibrous tumour of orbit. Asian J Neurosurg. 2017;12(1):55–57. doi:10.4103/1793-5482.144180.
  • Vu AF, Chundury RV, Blandford AD, Perry JD. Recurrent orbital solitary fibrous tumor in a 12-year-old. Ocul Oncol Pathol. 2017;3(2):83–86. doi:10.1159/000452151.
  • Shen J, Li H, Feng S, Cui H. Orbital solitary fibrous tumor: a clinicopathologic study from a Chinese tertiary hospital with a literature review. Cancer Manage Res. 2018;10:1069–1078. doi:10.2147/CMAR.S165218.
  • Sagiv O, Bell D, Guo Y, Su S, Wester ST, Jiang K, et al. Pathological features and clinical course in patients with recurrent or malignant orbital solitary fibrous tumor/hemangiopericytoma. Ophthalmic Plast Reconstr Surg. 2019;35(2):148–154. doi:10.1097/IOP.0000000000001189.
  • Rana N, Kim E, Jaboin J, Attia A. The role of adjuvant radiation in the management of solitary fibrous tumors of the central nervous system: a national cancer database analysis of 155 patients. Cureus. 2018;10(5):e2656. doi:10.7759/cureus.2656.
  • Stessin AM, Sison C, Nieto J, Raifu M, Li B. The role of postoperative radiation therapy in the treatment of meningeal hemangiopericytoma-experience from the SEER database. Int J Radiat Oncol Biol Phys. 2013;85(3):784–790. doi:10.1016/j.ijrobp.2012.05.042.
  • Levard A, Derbel O, Méeus P, Ranchère D, Ray-Coquard I, Blay J-Y, et al. Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience. BMC Cancer. 2013;13(1):109–7. doi:10.1186/1471-2407-13-109.
  • Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, et al. The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis. Clin Sarcoma Res. 2013;3(1):7–7. doi:10.1186/2045-3329-3-7.
  • Machado I, Morales MGN, Cruz J, Lavernia J, Giner F, Navarro S, et al. Solitary fibrous tumor: integration of clinical, morphologic, immunohistochemical and molecular findings in risk stratification and classification may better predict patient outcome. Int J Mol Sci. 2021;22(17):9423. doi:10.3390/ijms22179423.
  • Knight SWE, Knight TE, Santiago T, Murphy AJ, Abdelhafeez AH. Malignant peripheral nerve sheath tumors-a comprehensive review of pathophysiology, diagnosis, and multidisciplinary management. Children (Basel). 2022;9(1):38. doi:10.3390/children9010038.
  • Chikkannaiah P, Boovalli MM, Nathiyal V, Venkataramappa S. Morphological spectrum of peripheral nerve sheath tumors: an insight into World Health Organization 2013 classification. J Neurosci Rural Pract. 2019;07(3):346–354. doi:10.4103/0976-3147.182768.
  • Goldblum JR, Weiss SW, Folpe AL. Enzinger and Weiss’s Soft Tissue Tumors. 7 th ed. Philadelphia, PA : Elsevier; 2019.
  • Dutton JJ, Tawfik HA, DeBacker CM, Lipham WJ, Gayre GS, Klintworth GK. Multiple recurrences in malignant peripheral nerve sheath tumor of the orbit: a case report and a review of the literature. Ophthalmic Plast Reconstr Surg. 2001;17(4):293–299. doi:10.1097/00002341-200107000-00010.
  • Gündüz K. Peripheral nerve tumours. In: Karcioglu Z, ed. Orbital Tumors. 2nd ed. New York: Springer; 2015: 209–216.
  • Jones KE, Patel A, Kunesh MG, Thuro BA. Malignant peripheral nerve sheath tumor of the orbit: a case report and review of the literature. Orbit. 2021 April;41:1–5. doi:10.1080/01676830.2021.1918178.
  • Prescott DK, Racz MM, Ng JD. Epithelioid malignant peripheral nerve sheath tumor in the infraorbital nerve. Ophthalmic Plast Reconstr Surg. 2006;22(2):150–151. doi:10.1097/01.iop.0000200899.47766.80.
  • Barh A, Mukherjee B, Koka K, Krishnakumar S. Triton tumor of the orbit. Orbit. 2020;39(6):418–421. doi:10.1080/01676830.2019.1692873.
  • Sweeney AR, Gupta D, Keene CD, Cimino PJ, Chambers CB, Chang S-H, et al. Orbital peripheral nerve sheath tumors. Surv Ophthalmol. 2017;62(1):43–57. doi:10.1016/j.survophthal.2016.08.002.
  • Lyons CJ, McNab AA, Garner A, Wright JE. Orbital malignant peripheral nerve sheath tumours. Br J Ophthalmol. 1989;73(9):731–738. doi:10.1136/bjo.73.9.731.
  • Cleven AH, Sannaa Al GA, Briaire-de Bruijn I, Ingram DR, van de Rijn M, Rubin BP, et al. Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Mod Pathol. 2016;29(9):1113–1113. doi:10.1038/modpathol.2016.103.
  • Wang Y, Katagiri H, Murata H, Wasa J, Miyagi M, Kakuda Y, et al. Metastatic malignant peripheral nerve sheath tumor with NF1 successfully treated with ‘gradual subtraction’ ICE chemotherapy. Anticancer Res. 2020;40(3):1619–1624. doi:10.21873/anticanres.14110.
  • Lane CM, Wright JE, Garner A. Primary myxoid liposarcoma of the orbit. Br J Ophthalmol. 1988;72(12):912–917. doi:10.1136/bjo.72.12.912.
  • Jakobiec FA, Rini F, Char D, Orcutt J, Rootman J, Baylis H, et al. Primary liposarcoma of the orbit. Problems in the diagnosis and management of five cases. Ophthalmology. 1989;96(2):180–191. doi:10.1016/s0161-6420(89)32916-2.
  • McNab AA, Moseley I. Primary orbital liposarcoma: clinical and computed tomographic features. Br J Ophthalmol. 1990;74(7):437–439. doi:10.1136/bjo.74.7.437.
  • Cai YC, McMenamin ME, Rose G, Sandy CJ, Cree IA, Fletcher CD. Primary liposarcoma of the orbit: a clinicopathologic study of seven cases. Ann Diagn Pathol. 2001;5(5):255–266. doi:10.1053/adpa.2001.27911.
  • Garrity JA, Henderson JW, Cameron JD. Henderson’s tumors of primitive mesoderm, striated muscle, adipose tissue and smooth muscle. In: Garrity J, Henderson J, and Cameron J, eds. Henderson’s orbital tumors. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2007: 123–141.
  • Mridha AR, Sharma MC, Sarkar C, Suri V, Garg A, Suri A. Primary liposarcoma of the orbit: a report of two cases. Can J Ophthalmol. 2007;42(3):481–483. doi:10.3129/i07-072.
  • Madge SN, Tumuluri K, Strianese D, Bonavolonta P, Wilcsek G, Dodd TJ, et al. Primary orbital liposarcoma. Ophthalmology. 2010;117(3):606–614. doi:10.1016/j.ophtha.2009.08.017.
  • Al-Qahtani AA, Al-Hussain H, Chaudhry I, El-Khamary S, Alkatan HM. Primary orbital liposarcoma: histopathologic report of two cases. Middle East Afr J Ophthalmol. 2011;18(4):314–316. doi:10.4103/0974-9233.90135.
  • Khurana S, Gupta AK, Sen S, Kashyap S. Primary liposarcoma of the orbit. Indian J Pathol Microbiol. 2014;57(4):617–619. doi:10.4103/0377-4929.142700.
  • Kang JY, Kim HJ, Wojno TH, Yeung AM, Mendoza PR, Grossniklaus HE. Atypical lipomatous tumor/well-differentiated liposarcoma of the orbit: three cases and review of the literature. Ophthalmic Plast Reconstr Surg. 2021;37(3S):S134–140. doi:10.1097/IOP.0000000000001804.
  • Doyle M, Odashiro AN, Pereira PR, Odashiro M, Kobayashi F, Shinzato I, et al. Primary pleomorphic liposarcoma of the orbit: a case report. Orbit. 2012;31(3):168–170. doi:10.3109/01676830.2011.648806.
  • Wang L, Ren W, Zhou X, Sheng W, Wang J. Pleomorphic liposarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic study of 32 additional cases. Pathol Int. 2013;63(11):523–531. doi:10.1111/pin.12104.
  • Andrea T, Giulio G, Giuliana L, Sandro P. Primary dedifferentiated liposarcoma of the orbit, a rare entity: case report and review of literature. Saudi J Ophthalmol. 2019;33(3):312–315. doi:10.1016/j.sjopt.2019.01.003.
  • Daniel CS, Beaconsfield M, Rose GE, Luthert PJ, Heathcote JG, Clark BJ. Pleomorphic lipoma of the orbit: a case series and review of literature. Ophthalmology. 2003;110(1):101–105. doi:10.1016/s0161-6420(02)01450-1.
  • Tripathy D, Mittal R. Spindle cell lipoma of the orbit. Ophthalmic Plast Reconstr Surg. 2015;31(3):e53–55. doi:10.1097/IOP.0000000000000068.
  • Weaver J, Rao P, Goldblum JR, Joyce MJ, Turner SL, Lazar AJF, et al. Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma? Mod Pathol. 2010;23(10):1301–1306. doi:10.1038/modpathol.2010.106.
  • Crago AM, Dickson MA. Liposarcoma: multimodality management and future targeted therapies. Surg Oncol Clin N Am. 2016;25(4):761–773. doi:10.1016/j.soc.2016.05.007.
  • Jones RL, Fisher C, Al-Muderis O, Judson IR. Differential sensitivity of liposarcoma subtypes to chemotherapy. Eur J Cancer. 2005;41(18):2853–2860. doi:10.1016/j.ejca.2005.07.023.
  • Kleinerman RA, Schonfeld SJ, Sigel BS, Wong-Siegel JR, Gilbert ES, Abramson DH, et al. Bone and soft-tissue sarcoma risk in long-term survivors of hereditary retinoblastoma treated with radiation. J Clin Oncol. 2019;37(35):3436–3445. doi:10.1200/JCO.19.01096.
  • Kleinerman RA, Tucker MA, Abramson DH, Seddon JM, Tarone RE, Fraumeni JF. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst. 2007;99(1):24–31. doi:10.1093/jnci/djk002.
  • Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol. 2005;23(10):2272–2279. doi:10.1200/JCO.2005.05.054.
  • Baker KS, Leisenring WM, Goodman PJ, Ermoian RP, Flowers ME, Schoch G, et al. Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation. Blood. 2019;133(26):2790–2799. doi:10.1182/blood.2018874115.
  • Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socíe G, Travis LB, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336(13):897–904. doi:10.1056/NEJM199703273361301.
  • Socíe G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol. 2000;18(2):348–357. doi:10.1200/JCO.2000.18.2.348.
  • Harper GD, Dicks-Mireaux C, Leiper AD. Total body irradiation-induced osteochondromata. J Pediatr Orthop. 1998;18(3):356–358. doi:10.1097/01241398-199805000-00016.
  • Kebudi R, Ozger H, Kızılocak H, Bay SB, Bilgiç B. Osteosarcoma after hematopoietic stem cell transplantation in children and adolescents: case report and review of the literature. Pediatr Blood Cancer. 2016;63(9):1664–1666. doi:10.1002/pbc.26067.
  • Pierobon M, Mercolini F, Affinita MC, Tombolan L, Battisti L, Bisogno G. Secondary osteosarcoma after bone marrow transplant: an aggressive disease. J Adolesc Young Adult Oncol. 2020;9(6):672–675. doi:10.1089/jayao.2020.0054.
  • Scheuermann A, Phelan R, Browning M. Development of secondary osteosarcoma after TBI and allogeneic bone marrow transplant: a case series of 3 patients. J Pediatr Hematol Oncol. 2020;42(2):e100–103. doi:10.1097/MPH.0000000000001442.
  • Bjerkehagen B, Smeland S, Walberg L, Skjeldal S, Hall KS, Nesland JM, et al. Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital. Acta Oncol. 2008;47(8):1475–1482. doi:10.1080/02841860802047387.
  • Kauffman SL, Stout AP. Extraskeletal osteogenic sarcomas and chondrosarcomas in children. Cancer. 1963;16(4):432–439. doi:10.1002/1097-0142(196304)16:4<432:aid-cncr2820160403>3.0.co;2-e.
  • Jacob R, Abraham E, Jyothirmayi R, Nair MK. Extraskeletal osteosarcoma of the orbit. Sarcoma. 1998;2(2):121–124. doi:10.1080/13577149878082.
  • Fan JC, Lamont DL, Greenbaum AR, Ng SGJ. Primary orbital extraskeletal osteosarcoma. Orbit. 2011;30(6):297–299. doi:10.3109/01676830.2011.602170.
  • de Maeyer VMDS, Kestelyn PAFA, Shah AD, Van Den Broecke CM, Denys HGN, Decock CE. Extraskeletal osteosarcoma of the orbit: a clinicopathologic case report and review of literature. Indian, J Ophthalmol. 2016;64(9):687–689. doi:10.4103/0301-4738.97555.
  • Hui J, Zhao Y, Zhang L, Lin J, Zhao H. Primary orbital extraskeletal osteosarcoma and review of literature. BMC Ophthalmol. 2020;20(1):425–425. doi:10.1186/s12886-020-01690-9.
  • Mark RJ, Poen J, Tran LM, Fu YS, Selch MT, Parker RG. Postirradiation sarcomas. A single-institution study and review of the literature. Cancer. 1994;73(10):2653–2662. doi:10.1002/1097-0142(19940515)73:10<2653:aid-cncr2820731030>3.0.co;2-g.
  • Brady MS, Gaynor JJ, Brennan MF. Radiation-associated sarcoma of bone and soft tissue. Arch Surg. 1992;127(12):1379–1385. doi:10.1001/archsurg.1992.01420120013002.
  • Cha C, Antonescu CR, Quan ML, Maru S, Brennan MF. Long-term results with resection of radiation-induced soft tissue sarcomas. Ann Surg. 2004;239(6):903–9–discussion909–10. doi:10.1097/01.sla.0000128686.51815.8b.
  • Huvos AG, Woodard HQ, Cahan WG, Higinbotham NL, Stewart FW, Butler A, et al. Postradiation osteogenic sarcoma of bone and soft tissues. A clinicopathologic study of 66 patients. Cancer. 1985;55(6):1244–1255. doi:10.1002/1097-0142(19850315)55:6<1244:aid-cncr2820550617>3.0.co;2-1.
  • Yap J, Chuba PJ, Thomas R, Aref A, Lucas D, Severson RK, et al. Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2002;52(5):1231–1237. doi:10.1016/s0360-3016(01)02799-7.
  • Cahan WG, Woodard HQ. Sarcoma arising in irradiated bone; report of 11 cases. Cancer. 1948;1(1):3–29. doi:10.1002/1097-0142(194805)1:1<3:aid-cncr2820010103>3.0.co;2-7.
  • Gladdy RA, Qin L-X, Moraco N, Edgar MA, Antonescu CR, Alektiar KM, et al. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol. 2010;28(12):2064–2069. doi:10.1200/JCO.2009.25.1728.
  • Robinson E, Neugut AI, Wylie P. Clinical aspects of postirradiation sarcomas. J Natl Cancer Inst. 1988;80(4):233–240. doi:10.1093/jnci/80.4.233.
  • Wiklund TA, Blomqvist CP, Räty J, Elomaa I, Rissanen P, Miettinen M. Postirradiation sarcoma. Analysis of a nationwide cancer registry material. Cancer. 1991;68(3):524–531. doi:10.1002/1097-0142(19910801)68:3<524:aid-cncr2820680313>3.0.co;2-e.
  • Neuhaus SJ, Pinnock N, Giblin V, Fisher C, Thway K, Thomas JM, et al. Treatment and outcome of radiation-induced soft-tissue sarcomas at a specialist institution. Eur J Surg Oncol. 2009;35(6):654–659. doi:10.1016/j.ejso.2008.11.008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.